Abstract:CD47 is a ligand of the inhibitory receptor, signal regulatory protein (SIRP)alpha, and its interaction with SIRP alpha on macrophages prevents phagocytosis of autologous hematopoietic cells. CD47-SIRP alpha signaling also regulates dendritic cell (DC) endocytosis, activation, and maturation. In this study, we show that CD47 expression on donor cells plays an important role in suppression of allograft rejection by donor-specific transfusion (DST). DST was performed by i.v. injection of splenocytes from C57BL/6 donors into MHC class I-disparate brut mice 7 d prior to donor skin grafting. Administration of wild-type (WT) C57BL/6 donor splenocytes markedly prolonged donor skin survival in bm1 mouse recipients. In contrast, bm1 mice receiving DST from CD47 knockout (KO) donors showed no inhibition or even acceleration of donor skin graft rejection compared with non-DST control (naive) brut mice. T cells from bm1 mice receiving CD47 KO, but not WT, DST exhibited strong anti-donor responses. The ability of DST to suppress alloresponses was positively correlated with the density of CD47 molecules on donor cells, as CD47(+/-) DST was able to prolonged donor skin survival, but to a significantly less extent than WT DST. Furthermore, DCs from CD47 KO, but not WT, DST recipients showed rapid activation and contributed to donor skin rejection. These results show for the first time that CD47 on donor cells is required to repress recipient DC activation and suppress allograft rejection after DST, and suggest CD47 as a potential target for facilitating the induction of transplant tolerance. The Journal of Immunology, 2010, 184: 3401-3407.

CD47 in xenograft rejection and tolerance induction.

CD47: a New Player in Phagocytosis and Xenograft Rejection

CD47 is Required for Suppression of Allograft Rejection by Donor-Specific Transfusion

Survival and Function of Cd47-Deficient Thymic Grafts in Mice

Role for CD47-SIRPα Signaling in Xenograft Rejection by Macrophages

Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation.

Elimination of Donor CD47 Protects Against Vascularized Allograft Rejection in Mice.

Innate Cellular Immunity and Xenotransplantation.

Targeting CD47: the Achievements and Concerns of Current Studies on Cancer Immunotherapy

The Innate Cellular Immune Response in Xenotransplantation

Attenuation of Phagocytosis of Xenogeneic Cells by Manipulating CD47.

[Xenogeneic Antigens and Immune Response in Pig to Man Xenograft].

Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation

Transplant Tolerance: Current Insights and Strategies for Long-Term Survival of Xenografts

Current status of xenotransplantation research and the strategies for preventing xenograft rejection

Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice That Express SIRPα Capable of Binding to Human CD47

Macrophages in the rejection of xenogeneic red blood cells

Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis

Xenotransplantation: Current Challenges and Emerging Solutions

[Mechanisms of xenotransplant rejection].

Targeting CD47-SIRPα Axis for Hodgkin and Non-Hodgkin Lymphoma Immunotherapy